Free Expedited Rx ShippingFree ConsultationBoard-Certified Care
A single unbranded injection pen and glass vial on a warm off-white background

Weight Loss

Tirzepatide

Dual-action weight loss. One injection. Real results.

Tirzepatide is a first-in-class dual GIP and GLP-1 receptor agonist that works on two separate hunger-regulating pathways at once. That dual action makes it one of the most effective tools available for meaningful, sustained weight loss.

Starting at $249.99/month

10% off your first month. Reflects the 1-month intro price.

Get Started

Available in all 50 states.

Free telehealth consultation. Pay only if a provider approves your treatment plan.

A licensed provider determines the right dose for you.

HSA and FSA accepted.

Compounded in a licensed pharmacy.

Why patients choose Medura.

Real providers, not AI

Every treatment plan is reviewed by a board-certified provider who has time to know your full medical history, not just your symptoms.

Transparent pricing, no surprises

See the exact price before you start. No hidden fees, no surprise charges at checkout, no auto-escalating "optimization" costs.

Made in FDA-registered U.S. facilities

Compounded and quality-tested domestically. Discreet packaging. We cover shipping on all plans.

Support that actually listens

Your care team stays with you long after the first shipment. Real check-ins, dose adjustments based on how you actually feel, and honest answers to real questions.

What this is

Tirzepatide is a first-in-class dual GIP and GLP-1 receptor agonist that works on two separate hunger-regulating pathways at once. That dual action makes it one of the most effective tools available for meaningful, sustained weight loss.

A board-certified provider builds your plan, starts you at a low dose, and guides you upward at a pace your body can handle. You get real clinical support, not a generic protocol.

What to expect

Your treatment timeline, so you know what's coming and when to expect real changes.

  1. 1

    Two hormones, one injection

    Tirzepatide activates both GIP and GLP-1 receptors, targeting appetite from two distinct biological pathways, something no single-agonist treatment can match.

  2. 2

    Gradual dose titration

    You start low and increase on a schedule your provider controls. This keeps side effects manageable while your body adapts.

  3. 3

    Results that compound

    Most patients notice reduced hunger and improved satiety in the first weeks. Significant body weight changes build over months with consistent dosing.

How Tirzepatide works differently

Unlike older GLP-1 medications, Tirzepatide activates two separate gut hormone receptors. This dual mechanism has produced some of the highest average weight loss results ever recorded in a clinical obesity trial.

  • Dual-receptor action

    By targeting both GIP and GLP-1 receptors, Tirzepatide signals fullness more completely than a single-agonist approach, reducing both hunger and caloric intake.

  • Clinically significant weight loss

    In clinical trials, patients on the highest dose lost an average of 22% of their body weight over 72 weeks, among the strongest outcomes ever documented.

  • Provider-guided from day one

    A licensed provider reviews your history, sets your starting dose, and stays available to adjust your plan based on how you respond.

A woman smiling while preparing a healthy colorful meal in a bright kitchen

"I tried semaglutide before but stalled out. Tirzepatide completely changed things. The hunger just stopped being a constant battle."

Monica R.

Down 34 lbs in 5 months

Results vary. Individual outcomes depend on the user's starting point, adherence to the treatment plan, lifestyle factors, and overall health.

Questions, answered

You might also explore

The version of you that you miss is still in there.

Start with a free consultation. No pressure, no commitment, just a conversation about what is possible.